Baseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes
Diabetology international · 2027 Jan · Okuma H et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 30 20:00 ETSource: Diabetology international
From the source
Read at pubmed.ncbi.nlm.nih.govBaseline monocyte GIP receptor mRNA expression is associated with reductions in body weight and FIB-4 index after switching to tirzepatide in patients with type 2 diabetes
Diabetology international · 2027 Jan · Okuma H et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42968811/
